Skip to content
healthcare.dev

CARBAMAZEPINE

NDC 16571-681, CARBAMAZEPINE, tablet, extended release, from Rising Pharma Holdings, Inc..

Product NDC
16571-681
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211623
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-681 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE200 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
16571-681-0116571068101100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-681-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bf1590a0-68a7-45ed-817e-f97366f96ec4
  • NADAC price for package 16571068101

    GET /v1/drugs/nadac/16571068101

Use it

Look up 16571-681 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-681 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-681. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.